Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tact.ai provides an AI-powered customer engagement platform specifically designed for the life sciences industry. The platform acts as a human-friendly interface for CRM systems like Veeva or Salesforce, helping field teams such as Medical Science Liaisons and sales representatives manage relationships with healthcare professionals more effectively. By leveraging AI and a mobile-first design, Tact.ai streamlines workflows, improves data quality, and enhances the productivity of commercial and medical teams. The company's technology integrates various data sources into a single, conversational interface accessible via mobile, voice, and email. Tact.ai is backed by major industry players including Novartis, Eli Lilly, and McKesson, reflecting its strategic importance in pharmaceutical commercial operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tact.ai.